Reshape Biotech

Executive Summary

Reshape Biotech, a Danish company founded in 2019, offers a scalable robotic platform that integrates incubation and automated imaging for life science R&D and quality control labs. The system digitizes plate-based microbiological assays, leveraging AI to analyze experiments in real-time, thereby increasing efficiency, data quality, and reproducibility. Its cloud-based Discovery Platform centralizes experiment data, enabling seamless collaboration and data-driven decision-making. By automating manual, error-prone workflows, Reshape aims to accelerate drug discovery, improve quality control, and reduce costs for pharmaceutical, biotech, and food safety industries.

Upcoming Catalysts (preview)

• TBDLaunch of next-generation robotic platform with enhanced capabilities65% success
• TBDSeries B funding round to scale commercial operations70% success
• TBDStrategic partnership with a major pharmaceutical company60% success